<?xml version="1.0" encoding="UTF-8"?><BillSummaries>
<item congress="114" measure-type="hr" measure-number="3680" measure-id="id114hr3680" originChamber="HOUSE" orig-publish-date="2015-10-01" update-date="2016-07-07">
<title>Co-Prescribing to Reduce Overdoses Act of 2016</title>
<summary summary-id="id114hr3680v36" currentChamber="HOUSE" update-date="2016-07-07">
<action-date>2016-05-11</action-date>
<action-desc>Passed House amended</action-desc>
<summary-text><![CDATA[<p><b>Co-Prescribing to Reduce Overdoses Act of 2016</b></p> <p>(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)</p> <p>Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.</p> <p>(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.</p> <p>(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.</p>]]></summary-text>
</summary>
<summary summary-id="id114hr3680v17" currentChamber="HOUSE" update-date="2016-06-07">
<action-date>2016-05-10</action-date>
<action-desc>Reported to House amended</action-desc>
<summary-text><![CDATA[<p><b>Co-Prescribing to Reduce Overdoses Act of 2016</b></p> <p>(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)</p> <p>Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.</p> <p>(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.</p> <p>(Sec. 4) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.</p>]]></summary-text>
</summary>
<summary summary-id="id114hr3680v00" currentChamber="HOUSE" update-date="2016-05-09">
<action-date>2015-10-01</action-date>
<action-desc>Introduced in House</action-desc>
<summary-text><![CDATA[<p><b>Co-Prescribing to Reduce Overdoses Act of 2015</b></p> <p>This bill requires the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)</p> <p>Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists on prescription of such drugs, track patients and outcomes, and for other specified activities.</p> HHS must award grants to certain community groups and state and municipal health departments to develop guidelines on prescribing opioid overdose reversal drugs.]]></summary-text>
</summary>
</item>
<dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
<dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
<dc:description>This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
</dublinCore>
</BillSummaries>
